Geneoscopy

Cancer screening revolution

This company develops non-invasive stool-based DNA tests for the detection of colorectal cancer in adults aged forty-five and older.

CRCbioscreen

This company develops a stool-based diagnostic test to improve colorectal cancer screening for healthcare providers and national screening programmes.

Origin Sciences

This company develops medical devices and genomic tests for the detection and monitoring of gastrointestinal diseases for healthcare providers and clinical researchers.

Cernostics

This company develops image analysis tests for tissue biopsies to predict cancer risk in patients with Barrett's esophagus for gastroenterologists and clinicians.

Genecker

Genecker develops CRISPR-based liquid biopsy platforms for early cancer detection and recurrence monitoring, serving healthcare providers and research institutions.

Molecular Stethoscope

This company develops blood-based liquid biopsy tests that analyse cell-free messenger RNA to help clinicians and researchers detect and monitor diseases.

Guardant

The company develops blood-based liquid biopsy tests for cancer screening and monitoring for patients and healthcare providers.

Iterative Scopes

This company develops artificial intelligence software for gastroenterology to assist clinicians with polyp detection and clinical trial recruitment.